These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26844248)

  • 1. The Action Duchenne 13th International Annual Conference, November 6-7, 2015, London, UK.
    Ribeiro D; Stuckey DW
    EBioMedicine; 2015 Dec; 2(12):1836-7. PubMed ID: 26844248
    [No Abstract]   [Full Text] [Related]  

  • 2. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.
    McNally EM; Wyatt EJ
    Circulation; 2017 Sep; 136(11):979-981. PubMed ID: 28893959
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of novel therapeutic approaches for Duchenne muscular dystrophy].
    Takeshima Y
    No To Hattatsu; 2014 Mar; 46(2):109-14. PubMed ID: 24738186
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of immunosuppression in gene- and cell-based treatments for duchenne muscular dystrophy.
    Arruda VR
    Mol Ther; 2007 Jun; 15(6):1040-1. PubMed ID: 17510638
    [No Abstract]   [Full Text] [Related]  

  • 6. Dystrophin as a therapeutic biomarker: are we ignoring data from the past?
    Wilton SD; Fletcher S; Flanigan KM
    Neuromuscul Disord; 2014 Jun; 24(6):463-6. PubMed ID: 24767581
    [No Abstract]   [Full Text] [Related]  

  • 7. [Frontline studies on Duchenne muscular dystrophy treatment].
    Matsuo M
    No To Hattatsu; 2009 Mar; 41(2):92-5. PubMed ID: 19517771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to the therapy of Duchenne muscular dystrophy with early precursors of myogenesis.
    Sukhikh GT; Malaitsev VV; Bogdanova IM; Dubrovina IV; Sitnikov VF
    Bull Exp Biol Med; 2001 Dec; 132(6):1131-8. PubMed ID: 12152867
    [No Abstract]   [Full Text] [Related]  

  • 9. [Exon skipping therapy for Duchenne muscular dystrophy: outcome of preclinical study and prospective for clinical study].
    Nakamura A; Takeda S
    No To Hattatsu; 2010 Mar; 42(2):117-23. PubMed ID: 23858595
    [No Abstract]   [Full Text] [Related]  

  • 10. The search for a cure for Duchenne muscular dystrophy (DMD).
    Acta Myol; 2005 Dec; 24(3):169-71. PubMed ID: 16629049
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
    Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy and steroids: pharmacologic treatment in the absence of effective gene therapy.
    Alman BA
    J Pediatr Orthop; 2005; 25(4):554-6. PubMed ID: 15958914
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy.
    Willcocks RJ; Forbes SC; Walter GA; Sweeney L; Rodino-Klapac LR; Mendell JR; Vandenborne K
    JAMA Netw Open; 2021 Jan; 4(1):e2031851. PubMed ID: 33394000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation-specific treatments for Duchenne muscular dystrophy].
    Matsuo M; Takeshima Y
    Brain Nerve; 2009 Aug; 61(8):915-22. PubMed ID: 19697880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon-skipping therapy for Duchenne muscular dystrophy.
    Nakamura A; Takeda S
    Neuropathology; 2009 Aug; 29(4):494-501. PubMed ID: 19486303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less is more: therapeutic exon skipping for Duchenne muscular dystrophy.
    Aartsma-Rus A; van Ommen GJ
    Lancet Neurol; 2009 Oct; 8(10):873-5. PubMed ID: 19713153
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, Duchenne.
    Dasouki M; Barohn R; Zhu H
    Hum Genet; 2010 Jan; 127(1):109. PubMed ID: 19898871
    [No Abstract]   [Full Text] [Related]  

  • 18. Exon Skipping Therapy.
    Young CS; Pyle AD
    Cell; 2016 Nov; 167(5):1144. PubMed ID: 27863231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular therapy for duchenne muscular dystrophy].
    Takeshima Y
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():626-31. PubMed ID: 16416864
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel human pathological mutations. Gene symbol: DMD. Disease: Muscular Dystrophy, Duchenne.
    Dasouki M; Barohn R; Hegde M
    Hum Genet; 2010 Jan; 127(1):109. PubMed ID: 20108418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.